Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AD-303A
- Development stage
- Phase 2
- Lead developer
- Moogene Medi
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Administration
- Topical
01
Overview
AD-303A is a topical nanoparticle formulation of dutasteride being developed by Moogene Medi for the treatment of androgenetic alopecia. The drug utilizes Moogene Medi's proprietary lipid nanoparticle (LNP) or nanoparticle-based drug delivery system (Moo-DDS) to facilitate the delivery of dutasteride directly to the hair follicles in the scalp. This localized delivery approach is designed to enhance therapeutic efficacy while minimizing systemic absorption, thereby reducing the risk of systemic side effects typically associated with oral 5-alpha reductase inhibitors, such as sexual dysfunction. Dutasteride, the active pharmaceutical ingredient, is a potent inhibitor of both Type I and Type II isoforms of the 5-alpha reductase enzyme, which prevents the conversion of testosterone into dihydrotestosterone (DHT), the primary hormone responsible for hair follicle miniaturization in androgenetic alopecia.
- Other names
- topical dutasteride
Beyond the preview
Go deeper on AD-303A.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AD-303A.